News Industry News BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle June 27, 2016
News Industry News BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology December 13, 2015
News Industry News BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode December 08, 2015